Expression of vascular endothelial-cadherin in human hepatocellular carcinoma tissues

Hepatology Research

Volumn 37, Issue 6, 2007, Pages 444-453

  Kato, Kenichirou ^a   Takada, Tadahiro ^a   Fukusato, Toshio ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Immunoelectron microscopic study; Immunohistochemistry; Vascular endothelial cadherin; Western blot

Indexed keywords

VASCULAR ENDOTHELIAL CADHERIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER INVASION; CAPILLARY ENDOTHELIUM; CELL DIFFERENTIATION; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOTHELIUM CELL; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER SINUSOID; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 34250303153     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00051.x     Document Type: Article

References (31)

1. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15-18.
2. Sharma S, Sharma MC, Sarkar C. Morphology and angiogenesis in human cancer: A conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005; 46: 481-9.
3. El-Assall ON, Yamanoi A, Soda Y et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998; 27: 1554-62.
4. Maeda T, Adachi E, Kajiyama K et al. CD34 expression in endothelial cells of small hepatocellular carcinoma: Its correlation with tumor progression and angiographic findings. J Gastroenterol Hepatol 1995; 10: 650-4.
5. Ruck P, Xiao JC, Kaiserling E. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Arch Pathol Lab Med 1995; 119: 173-8.
6. Kimura H, Nakajima T, Kagawa K et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 1998; 18: 14-19.
7. Gouysse G, Frachon S, Hervieu V et al. Endothelial cell differentiation in hepatocellular adenomas: Implications for histopathological diagnosis. J Hepatol 2004; 41: 259-66.
8. Ho JW, Poon RT, Sun CK, Xue WC, Fan ST. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. World J Gastroenterol 2005; 11: 176-81.
9. Scoazec J-Y, Racine L, Couvelard A, Flejou J-F, Feldmann G. Endothelial cell heterogeneity in the normal human liver acinus: In situ immunohistochemical demonstration. Liver 1994; 14: 113-23.
10. Ohmori S, Shiraki K, Sugimoto K et al. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol 2001; 32: 1363-70.
11. Frachon S, Gouysse G, Dumortier J et al. Endothelial cell marker expression in dysplastic lesions of the liver: An immunohistochemical study. J Hepatol 2001; 34: 850-7.
12. Lampugnani MG, Resnati M, Raiteri M et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992; 118: 1511-22.
13. Suzuki S, Sano K, Tanihara H. Diversity of the cadherin family: Evidence for eight new cadherins in nervous tissue. Cell Regul 1991; 2: 261-70.
14. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: Molecular organization and role of vascular homeostasis. Physiol Rev 2004; 84: 869-901.
15. Garory-Faure S, Prandini MH, Pointu H et al. Role of vascular endothelial-cadherin in vascular morphogenesis. Development 1999; 126: 2093-102.
16. Cavallaro U, Leibner S, Dejana E. Endothelial cadherins and tumor angiogenesis. Exp Cell Res 2006; 312: 659-67.
17. Wallez Y, Vilgrain I, Huber P. Angiogenesis: The VE-cadherin switch. Trends Cardiovasc Med 2006; 16: 55-9.
18. Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, Garcia-Arroyo A, Garcia-Sanchez A, Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: Evidence of neoangiogenesis in portal tracts. Gastroenterology 1995; 108: 231-41.
19. Medina J, Caveda L, Sanz-Cameno P et al. Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis. J Hepatol 2003; 38: 660-7.
20. Medina J, Sanz-Cameno P, Garcia-Buey L, Martin-Vilchez S, Lopez-Cabrera M, Moreno-Otero R. Evidence of angiogenesis in primary biliary cirrhosis: An immunohistochemical descriptive study. J Hepatol 2005; 42: 124-31.
21. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. Tokyo: Kanehara, 1997.
22. Medina J, Arroyo AG, Sanchez-Madrid F, Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology 2004; 39: 1185-95.
23. Parker BS, Argani P, Cook BP et al. Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res 2004; 64: 7856-66.
24. Prandini MH, Dreher I, Bouillot S, Benkerri S, Moll T, Huber P. The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene 2005; 24: 2992-3001.
25. Fukuhara S, Sakurai A, Yamagishi A, Sako K, Mochizuki N. Vascular endothelial cadherin-mediated cell-cell adhesion regulated by a small GTPase, Rap1. J Biochem Mol Biol 2006; 39: 132-9.
26. Iurlaro M, Demontis F, Corada M et al. VE-cadherin expression and clustering maintain low levels of surviving in endothelial cells. Am J Pathol 2004; 165: 181-9.
27. Vincent L, Kermani P, Young LM et al. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling. J Clin Invest 2005; 115: 2992-3006.
28. Sulkowska M, Famulski W, Wincewicz A et al. Levels of VE-cadherin increase independently of VEGF in preoperative sera of patients with colorectal cancer. Tumori 2006; 92: 67-71.
29. Corada M, Zanetta L, Orsenigo F et al. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 2002; 100: 905-11.
30. Pierce M, Wang C, Stump M, Kamb A. Overexpression of the β-catenin binding domain of cadherin selectively kills colorectal cancer cells. Int J Cancer 2003; 107: 229-37.
31. Shin SC, Robinson GS, Perruzzi CA et al. Molecular profiling of angiogenesis markers. Am J Pathol 2002; 161: 35-41.